Licensing

SKY

IS

THE

LIMIT

Partnership Opportunities

LSC will consider licensing and development for custom design co-engineering of Hydroxysomes® with any API / bioactive including hydrophilic and hydrophobic actives. LSC will be responsible for the development and manufacturing of the new innovative active raw material.

This includes:

Stabilization Technology
Sustained Release
Dermal Delivery
Encapsulation Technology

Key Features

Damage-free/non-invasive
No need for penetration enhancers
Delivery through intact skin
Increased skin penetration
Highly stable, safe and non-toxic
Improved stability of bioactives
Sustained release
Increased efficiency/bio-availability
Non-irritating
Ease of formulation
UVA/UVB SPF Booster

Joint Ventures & Development of Topical Drugs With Pharmaceutical Partners

Pharmaceutical Applications:

Extend proprietary Protection & Provide Brand Evergreening
Development of Drug Product Intermediate (DPI)
Licensing and supply of DPI